Endovascular surgery in patients with coronary artery disease in combination with cancer

Purpose of the study. To analyze the long-term results from various strategies of endovascular treatment for coronary artery disease (CAD) in patients concomitant with cancer.Patients and methods. 74 patients with both CAD disease and cancer were treated in A. V. Vishnevskiy National Medical Researc...

Full description

Saved in:
Bibliographic Details
Main Authors: B. G. Alekyan, A. A. Gritskevich, N. G. Karapetyan, D. V. Ruchkin, A. A. Pechetov, P. V. Markov, B. N. Gurmikov, N. L. Irodova, L. G. Gyoletsyan, E. V. Tokmakov, A. V. Galstyan, A. Sh. Revishvili
Format: Article
Language:Russian
Published: ANO "Perspective of oncology" 2024-09-01
Series:Южно-Российский онкологический журнал
Subjects:
Online Access:https://www.cancersp.com/jour/article/view/287
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850063039884165120
author B. G. Alekyan
A. A. Gritskevich
N. G. Karapetyan
D. V. Ruchkin
A. A. Pechetov
P. V. Markov
B. N. Gurmikov
N. L. Irodova
L. G. Gyoletsyan
E. V. Tokmakov
A. V. Galstyan
A. Sh. Revishvili
author_facet B. G. Alekyan
A. A. Gritskevich
N. G. Karapetyan
D. V. Ruchkin
A. A. Pechetov
P. V. Markov
B. N. Gurmikov
N. L. Irodova
L. G. Gyoletsyan
E. V. Tokmakov
A. V. Galstyan
A. Sh. Revishvili
author_sort B. G. Alekyan
collection DOAJ
description Purpose of the study. To analyze the long-term results from various strategies of endovascular treatment for coronary artery disease (CAD) in patients concomitant with cancer.Patients and methods. 74 patients with both CAD disease and cancer were treated in A. V. Vishnevskiy National Medical Research Center of Surgery from 01/01/2018 to 12/31/2022. By a multidisciplinary council, patients were divided into three groups: group 1 (n = 39) – staged treatment: percutaneous coronary intervention (PCI) is the first stage, the second is surgical treatment of cancer; group 2 (n = 14) – staged treatment: the first stage was surgical treatment of cancer, and the second stage was PCI; group 3 (n = 21) – PCI and open surgery were performed on the same day.Results. In the immediate period, 3 (4.0 %) deaths were observed: 2 (5.1 %) in group 1, 1 (4.8 %) in group 3, the cause of which was complications arising after oncological surgical interventions. One (2.6 %) patient from group 1 had acute myocardial infarction (AMI) due to acute stent thrombosis in the left anterior descending artery (LAD). The patient underwent successful emergency PCI. In the long-term period, 15 (25.4 %) patients died, out of which 11 (18.7 %) from progression of cancer, and 4 (6.7 %) from other causes. Among the major cardiovascular complications, the following were observed: 1 (3.2 %) AMI in group 1 and 1 (7.1 %) in group 2.Conclusion. In the long-term follow-up period, the leading cause of death (73,3 %) was progression of cancer. There were no detected from deaths AMI, which confirms the importance and feasibility of myocardial revascularization in this severe group of patients. PCI in patients with coronary artery disease in combination with cancer allows for effective and safe surgical treatment of malignant pathology without cardiac mortality both in the immediate and long-term follow-up periods.
format Article
id doaj-art-dba7c59e02574537a2503de4fed4f09e
institution DOAJ
issn 2686-9039
language Russian
publishDate 2024-09-01
publisher ANO "Perspective of oncology"
record_format Article
series Южно-Российский онкологический журнал
spelling doaj-art-dba7c59e02574537a2503de4fed4f09e2025-08-20T02:49:46ZrusANO "Perspective of oncology"Южно-Российский онкологический журнал2686-90392024-09-0153394910.37748/2686-9039-2024-5-3-4160Endovascular surgery in patients with coronary artery disease in combination with cancerB. G. Alekyan0A. A. Gritskevich1N. G. Karapetyan2D. V. Ruchkin3A. A. Pechetov4P. V. Markov5B. N. Gurmikov6N. L. Irodova7L. G. Gyoletsyan8E. V. Tokmakov9A. V. Galstyan10A. Sh. Revishvili11A. V. Vishnevskiy National Medical Research Center of Surgery; Russian Medical Academy of Continous Professional EducationA. V. Vishnevskiy National Medical Research Center of SurgeryErebuni Medical CenterA. V. Vishnevskiy National Medical Research Center of SurgeryA. V. Vishnevskiy National Medical Research Center of SurgeryA. V. Vishnevskiy National Medical Research Center of SurgeryA. V. Vishnevskiy National Medical Research Center of SurgeryA. V. Vishnevskiy National Medical Research Center of SurgeryA. V. Vishnevskiy National Medical Research Center of SurgeryA. V. Vishnevskiy National Medical Research Center of SurgeryA. V. Vishnevskiy National Medical Research Center of SurgeryA. V. Vishnevskiy National Medical Research Center of SurgeryPurpose of the study. To analyze the long-term results from various strategies of endovascular treatment for coronary artery disease (CAD) in patients concomitant with cancer.Patients and methods. 74 patients with both CAD disease and cancer were treated in A. V. Vishnevskiy National Medical Research Center of Surgery from 01/01/2018 to 12/31/2022. By a multidisciplinary council, patients were divided into three groups: group 1 (n = 39) – staged treatment: percutaneous coronary intervention (PCI) is the first stage, the second is surgical treatment of cancer; group 2 (n = 14) – staged treatment: the first stage was surgical treatment of cancer, and the second stage was PCI; group 3 (n = 21) – PCI and open surgery were performed on the same day.Results. In the immediate period, 3 (4.0 %) deaths were observed: 2 (5.1 %) in group 1, 1 (4.8 %) in group 3, the cause of which was complications arising after oncological surgical interventions. One (2.6 %) patient from group 1 had acute myocardial infarction (AMI) due to acute stent thrombosis in the left anterior descending artery (LAD). The patient underwent successful emergency PCI. In the long-term period, 15 (25.4 %) patients died, out of which 11 (18.7 %) from progression of cancer, and 4 (6.7 %) from other causes. Among the major cardiovascular complications, the following were observed: 1 (3.2 %) AMI in group 1 and 1 (7.1 %) in group 2.Conclusion. In the long-term follow-up period, the leading cause of death (73,3 %) was progression of cancer. There were no detected from deaths AMI, which confirms the importance and feasibility of myocardial revascularization in this severe group of patients. PCI in patients with coronary artery disease in combination with cancer allows for effective and safe surgical treatment of malignant pathology without cardiac mortality both in the immediate and long-term follow-up periods.https://www.cancersp.com/jour/article/view/287coronary artery diseasecancerpercutaneous coronary interventionmalignant neoplasmsurgical treatmentcoronary artery stenting
spellingShingle B. G. Alekyan
A. A. Gritskevich
N. G. Karapetyan
D. V. Ruchkin
A. A. Pechetov
P. V. Markov
B. N. Gurmikov
N. L. Irodova
L. G. Gyoletsyan
E. V. Tokmakov
A. V. Galstyan
A. Sh. Revishvili
Endovascular surgery in patients with coronary artery disease in combination with cancer
Южно-Российский онкологический журнал
coronary artery disease
cancer
percutaneous coronary intervention
malignant neoplasm
surgical treatment
coronary artery stenting
title Endovascular surgery in patients with coronary artery disease in combination with cancer
title_full Endovascular surgery in patients with coronary artery disease in combination with cancer
title_fullStr Endovascular surgery in patients with coronary artery disease in combination with cancer
title_full_unstemmed Endovascular surgery in patients with coronary artery disease in combination with cancer
title_short Endovascular surgery in patients with coronary artery disease in combination with cancer
title_sort endovascular surgery in patients with coronary artery disease in combination with cancer
topic coronary artery disease
cancer
percutaneous coronary intervention
malignant neoplasm
surgical treatment
coronary artery stenting
url https://www.cancersp.com/jour/article/view/287
work_keys_str_mv AT bgalekyan endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT aagritskevich endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT ngkarapetyan endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT dvruchkin endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT aapechetov endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT pvmarkov endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT bngurmikov endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT nlirodova endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT lggyoletsyan endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT evtokmakov endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT avgalstyan endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer
AT ashrevishvili endovascularsurgeryinpatientswithcoronaryarterydiseaseincombinationwithcancer